Transcriptional and post‐transcriptional mechanisms for lysophosphatidic acid‐induced cyclooxygenase‐2 expression in ovarian cancer cells
Open Access
- 24 March 2008
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 22 (8) , 2639-2651
- https://doi.org/10.1096/fj.07-101428
Abstract
Emerging evidence suggests that lysophosphatidic acid (LPA) is a physiological regulator of cyclooxygenase‐2 (Cox‐2) expression. Herein we used ovarian cancer cells as a model to investigate the mole...Keywords
Funding Information
- National Institutes of Health (CA102196)
- National Cancer Institute
- U.S. Department of Defense (W81XWH0410103)
- National Institutes of Health (P30 CA16059)
This publication has 63 references indexed in Scilit:
- CARMA3/Bcl10/MALT1-dependent NF-κB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cellsProceedings of the National Academy of Sciences, 2007
- Bcl10 plays a critical role in NF-κB activation induced by G protein-coupled receptorsProceedings of the National Academy of Sciences, 2007
- Cyclo-Oxygenase-2 and its Inhibition in CancerDrugs, 2007
- β-Catenin stabilizes Cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3′-UTRNucleic Acids Research, 2006
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2005
- Transcriptional Control of COX-2 via C/EBPβArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Expression of the ELAV-Like Protein HuR Is Associated with Higher Tumor Grade and Increased Cyclooxygenase-2 Expression in Human Breast CarcinomaClinical Cancer Research, 2004
- Mechanisms for Lysophosphatidic Acid-induced Cytokine Production in Ovarian Cancer CellsJournal of Biological Chemistry, 2004
- Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2)Oncogene, 2004
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003